1. Involuntary medication in psychiatric inpatient treatment
- Author
-
Maritta Välimäki, R. Kaltiala-Heino, C Tuohimäki, Ville Lehtinen, and Jyrki Korkeila
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,media_common.quotation_subject ,Patient Advocacy ,Psychiatric Department, Hospital ,Patient Readmission ,Hospitals, University ,Treatment Refusal ,03 medical and health sciences ,0302 clinical medicine ,Denial ,Risk Factors ,medicine ,Humans ,Medical prescription ,Psychiatry ,Finland ,Retrospective Studies ,0505 law ,media_common ,Psychiatric Status Rating Scales ,business.industry ,Public health ,05 social sciences ,Social environment ,Retrospective cohort study ,Middle Aged ,medicine.disease ,Mental health ,030227 psychiatry ,Psychiatry and Mental health ,Schizophrenia ,050501 criminology ,Commitment of Mentally Ill ,Female ,Schizophrenic Psychology ,business ,Antipsychotic Agents ,Diagnosis of schizophrenia - Abstract
The aim of this study was to examine involuntary medication in psychiatric inpatient treatment. A retrospective chart review of 1543 consecutive admissions of working aged civil patients from well-defined catchment areas to three psychiatric centres were evaluated regarding events of involuntary medication. 8.2% of the admissions included involuntary medication episode(s). Involuntary medication was associated with a diagnosis of schizophrenia, involuntary legal status and having previously been committed. One of the studied centres used less involuntary medication than the other two, even if patients with schizophrenia were over-represented in that centre. Although involuntary medication mainly takes places in the treatment of patients who are conceptualised most ill and perhaps resist treatment most, treatment culture obviously also plays a role. In future, it is important to study the aspects of treatment culture to fully understand the use of involuntary medication in psychiatry.
- Published
- 2003
- Full Text
- View/download PDF